| Literature DB >> 27857521 |
Mona Maria Talmaciu1, Ede Bodoki1, Radu Oprean1.
Abstract
BACKGROUND AND AIM: Beta-adrenergic antagonists have been established as first line treatment in the medical management of hypertension, acute coronary syndrome and other cardiovascular diseases, as well as for the prevention of initial episodes of gastrointestinal bleeding in patients with cirrhosis and esophageal varices, glaucoma, and have recently become the main form of treatment of infantile hemangiomas. The aim of the present study is to calculate for 14 beta-blockers several quantum chemical descriptors in order to interpret various molecular properties such as electronic structure, conformation, reactivity, in the interest of determining how such descriptors could have an impact on our understanding of the experimental observations and describing various aspects of chemical binding of beta-blockers in terms of these descriptors.Entities:
Keywords: beta-blockers; molecular orbitals; reactivity; stability
Year: 2016 PMID: 27857521 PMCID: PMC5111492 DOI: 10.15386/cjmed-610
Source DB: PubMed Journal: Clujul Med ISSN: 1222-2119
Chemical structure of beta-adrenoceptor blocking agents (a-acebutolol, b- alprenolol, c- atenolol, d- betaxolol, e- bisoprolol, f- carazolol, g- carvedilol, h- esmolol, i- metoprolol, j- oxprenolol, k- pindolol, l- propranolol, m- sotalol, n- timolol) * - asymmetric C.
Values of HOMO-LUMO gap (HLG)/Hardness and values of Softness.
| Molecule | AM1_ | PM3_ | MNDO_ | MNDO_Softness | PM3_Softness | AM1_Softness |
|---|---|---|---|---|---|---|
| HLG | HLG | HLG | ||||
| Acebutolol | 8.465 | 8.566 | 8.753 | 0.114 | 0.117 | 0.118 |
| Alprenolol | 9.370 | 9.405 | 9.023 | 0.111 | 0.106 | 0.107 |
| Atenolol | 9.259 | 9.279 | 8.994 | 0.111 | 0.108 | 0.108 |
| Betaxolol | 9.355 | 9.360 | 9.007 | 0.111 | 0.107 | 0.107 |
| Bisoprolol | 9.378 | 9.375 | 9.052 | 0.110 | 0.107 | 0.107 |
| Carazolol | 8.229 | 8.132 | 8.092 | 0.124 | 0.123 | 0.122 |
| Carvedilol | 8.230 | 8.123 | 8.056 | 0.124 | 0.123 | 0.121 |
| Esmolol | 9.341 | 9.345 | 9.045 | 0.111 | 0.107 | 0.107 |
| Metoprolol | 9.363 | 9.351 | 9.008 | 0.111 | 0.107 | 0.107 |
| Oxprenolol | 9.267 | 9.343 | 9.020 | 0.111 | 0.107 | 0.108 |
| Pindolol | 8.491 | 8.411 | 8.346 | 0.120 | 0.119 | 0.118 |
| Propranolol | 8.215 | 8.227 | 8.034 | 0.124 | 0.122 | 0.122 |
| Sotalol | 8.519 | 8.703 | 7.600 | 0.132 | 0.115 | 0.117 |
| Timolol | 8.347 | 8.048 | 8.825 | 0.113 | 0.124 | 0.120 |
Global Electrophilicity indexes.
| Molecule | MNDO_Global Electrophilicity | AM1_Global Electrophilicity | PM3_Global Electrophilicity |
|---|---|---|---|
| Acebutolol | 0.123 | 0.126 | 0.126 |
| Alprenolol | 0.115 | 0.111 | 0.112 |
| Atenolol | 0.120 | 0.116 | 0.116 |
| Betaxolol | 0.114 | 0.109 | 0.110 |
| Bisoprolol | 0.116 | 0.111 | 0.112 |
| Carazolol | 0.130 | 0.127 | 0.129 |
| Carvedilol | 0.129 | 0.127 | 0.130 |
| Esmolol | 0.118 | 0.112 | 0.114 |
| Metoprolol | 0.115 | 0.110 | 0.111 |
| Oxprenolol | 0.118 | 0.114 | 0.114 |
| Pindolol | 0.123 | 0.121 | 0.124 |
| Propranolol | 0.131 | 0.128 | 0.130 |
| Sotalol | 0.158 | 0.131 | 0.127 |
| Timolol | 0.125 | 0.127 | 0.138 |
Electronegativity.
| Molecule | AM1_ | MNDO_ | PM3_ |
|---|---|---|---|
| Electronegativity | Electronegativity | Electronegativity | |
| Acebutolol | 4.526 | 4.624 | 4.638 |
| Alprenolol | 4.292 | 4.313 | 4.433 |
| Atenolol | 4.598 | 4.634 | 4.631 |
| Betaxolol | 4.150 | 4.239 | 4.278 |
| Bisoprolol | 4.357 | 4.379 | 4.446 |
| Carazolol | 4.346 | 4.453 | 4.429 |
| Carvedilol | 4.353 | 4.341 | 4.485 |
| Esmolol | 4.401 | 4.585 | 4.525 |
| Metoprolol | 4.235 | 4.298 | 4.293 |
| Oxprenolol | 4.447 | 4.500 | 4.574 |
| Pindolol | 4.194 | 4.243 | 4.348 |
| Propranolol | 4.424 | 4.442 | 4.607 |
| Sotalol | 4.972 | 5.779 | 4.880 |
| Timolol | 4.492 | 4.849 | 4.933 |